top of page

hashimotos thyrOIDITis
Hashimoto's thyroiditis (HT), also known as chronic autoimmune thyroiditis, is the leading cause of hypothyroidism in cases of sufficient iodine intake in the world [12]. It is characterized by an immune-mediated attack on the thyroid gland, resulting in progressive thyroid dysfunction.
One key immunological aspect to HT is immune dysregulation, where the immune system becomes confused and starts attacking the thyroid gland by mistake. It sees parts of the thyroid, like the proteins thyroid peroxidase (TPO) and thyroglobulin (Tg) as threats, even though they’re normal. In response, the immune system makes autoantibodies that attack these proteins. [1][2][3]
These antibodies include:
Thyroid Peroxidase Antibodies (TPOAb)
-
Optimal range: < 9 IU/mL
-
Hashimoto's Thyroiditis: > 35 IU/mL
Thyroglobulin Antibodies (TgAb)
-
Optimal range: < 4 IU/mL
-
Hashimoto's Thyroiditis: > 20 IU/mL
The diagnosis of Hashimoto's is primarily established through elevated blood levels of thyroid-stimulating hormone (TSH), along with antibody titers, including TPOAb and TgAb [15], with the antibody levels correlating to the degree of disease activity.
Genetic studies have also identified strong associations with certain gene variants in immune-regulatory genes like CTLA-4 and PTPN22 [13]. However, the progression from genetic susceptibility to clinical disease requires a complex interplay of other factors such as viral infections, immune dysregulation, nutrient deficiencies, heavy metal exposure and oxidative stress.[12]
Clinically, HT usually presents as a hypofunctioning thyroid, with symptoms including fatigue, cold intolerance, weight gain, depression, and constipation among others [12]. Some patients may initially exhibit painless swelling of the lower neck, reflecting thyroid enlargement.
Treatment is essential not only to alleviate symptoms but because Hashimoto's autoantibodies and the immune dysregulation associated are strongly associated with the development of thyroid cancers, and may have systemic implications, affecting organs like the ovaries, liver, and stomach lining, emphasizing the importance of care [15][17][22]
Emerging evidence supports a more integrative treatment approach. Herbs, extracts and micronutrients such as selenium, vitamin D and myo-inositol have been clinically demonstrated to influence both thyroid hormone production and lower autoimmune antibodies, offering additional support beyond conventional thyroxine therapy. [12][13][14].
signs & symptoms
Clinically, Hashimoto's usually presents as a hypo-functioning thyroid, with symptoms including:
-
Dull and Dry Skin
-
Thinning and Brittle Hair
-
Low Energy
-
Cognitive Dysfunction and Brain Fog
-
Weight Fluctuations
-
Cold Intolerance
-
Depression
-
Anemia
-
Menstrual Irregularities and Infertility
-
Constipation
-
Cold Extremities
-
Hoarseness and Puffy Face
[1][2][3]
Goiter / Lower Neck Swelling
A goiter is swelling at the front of the neck, often around the base, where the thyroid gland sits. It can appear as a visible bulge and may be symmetrical (diffuse goiter) or lumpy (nodular goiter). It may be so subtle that only a doctor can detect it during a physical exam, while in others, it can become obvious. In cases of hashimoto’s it has been demonstrated that up to 60% of patients present with a form of goiter. [21]
Premature Ovarian Failure
Hashimoto's thyroiditis is not just a thyroid condition; it has systemic implications, particularly on female reproductive health.
A large-scale cohort study of over 21,000 women revealed that women with Hashimoto’s thyroiditis are at a significantly increased risk of developing premature ovarian insufficiency (POI). Specifically, the study found that these women have an 89% higher risk of experiencing a loss of the menstrual cycle, and are 2.4 times more likely to face infertility due to ovarian failure compared to women without autoimmune thyroid disease.[17]
Causes
Epstein-Barr Virus Latency
Epstein-Barr Virus (EBV), best known for causing glandular fever, infects over 90% of the world’s population. After the initial infection, EBV remains in the body in a dormant (latent) state, hiding inside immune cells. While dormant, it doesn't produce new viruses but continues to express certain viral proteins that can subtly influence the immune system.
Research shows a strong link between this latent EBV activity and the development of Hashimoto’s thyroiditis. In tissue samples from patients with Hashimoto’s, EBV was detected in over 80% of cases using a marker called EBER, which confirms the virus's presence in its latent form. Additionally, another EBV protein, LMP1, was found in about 34% of cases, further supporting its activity within thyroid tissue.
Furthermore, blood tests comparing 60 people with Hashimoto’s to 60 healthy individuals revealed that while all had signs of past EBV infection, about one-third of Hashimoto’s patients had elevated levels of EA IgG, a marker of viral reactivation. This was rare in the healthy group.
This suggests that not just past infection, but ongoing low-level reactivation of EBV may contribute to triggering or worsening Hashimoto’s. Interestingly, higher levels of EBNA-1 IgG, which is a marker of long-term viral latency, were linked to lower T3 thyroid hormone levels in patients, implying that more viral activity might suppress thyroid function.[4][5]
Treg Dysfunction
In Hashimoto’s thyroiditis, a specific part of immune protection, known as regulatory T cells (Tregs), which are essential for maintaining immune tolerance, often exhibit impaired function. This dysfunction permits self-reactive immune responses to continue unchecked, leading to the destruction of thyroid tissue and the production of autoantibodies such as anti-TPO and anti-Tg.[6]
Infections
A central underlying factor contributing to the immune imbalance, including Treg Dysfunction which correlates to the pathogenesis of Hashimoto's, is the presence of chronic infections, which serve as persistent immunological triggers. These include:
-
SIBO
-
Candiadiasis
-
Helminth infection
-
Protozoa Infection
-
Herpes Simplex Virus
-
Epstein Barr Virus
-
Mycotoxicosis
These infections drive the chronic elevation of interleukin-6 (IL-6) which plays a central role in immune dysregulation. IL-6 is a pro-inflammatory cytokine, and within the thyroid elevated IL-6 promotes the conversion of regulatory T cells (Tregs), which normally suppress inappropriate immune responses into pro-inflammatory Th17 cells, which contributes directly to the development and sustainment of Hashimoto's.[6]
Oxidative Stress
Oxidative stress plays a central role in the pathophysiology of Hashimoto’s. Excessive production of reactive oxygen species (ROS) leads to fat peroxidation, protein oxidation, and DNA damage within thyroid follicular cells. These oxidative insults compromise cellular membranes and mitochondrial function, ultimately resulting in thyrocyte damage and death.
It has been demonstrated in individuals with HT, antioxidant defense mechanisms are notably impaired. Studies have demonstrated reduced activity of key antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx), alongside a decline in total antioxidant capacity. Moreover, patients who test positive for thyroid peroxidase antibodies (TPOAb) exhibit significantly elevated oxidative stress markers, highlighting a strong association between autoimmune activity and antioxidant capacity [30].
Heavy Metal Toxicity
Cadmium
Cadmium, commonly released from industrial pollution and cigarette smoke, accumulates in various tissues including the thyroid gland. It induces oxidative stress and impairs the biosynthesis of thyroid hormones.
Cadmium has the strongest evidence linking it to Hashimoto’s. Several human studies have found a positive correlation between blood or urinary cadmium levels and elevated TPOAb and TgAb. The underlying mechanisms include oxidative stress, damage to thyroid follicular cells, and suppression of antioxidant enzyme production, which leads to immune dysregulation. Cadmium can also impair the function of thyroid-specific enzymes, increasing their antigenicity and promoting autoimmune reactivity.[8]
Lead
Lead is commonly found in old paints, gasoline, contaminated soil near older buildings, It can also be present in imported spices, and traditional cosmetics.
Lead exposure is also significantly associated with autoimmune thyroid activity. Research has shown that women with higher blood lead levels have an increased risk of developing thyroid autoimmunity, including higher TPOAb levels and a greater likelihood of hypothyroid symptoms. Lead disrupts thyroid hormone synthesis, alters immune tolerance, and may compromise the blood-thyroid barrier, which allows immune cells to access thyroid antigens, triggering antibody formation.[8]
Arsenic
Exposure to Arsenic can take place from contaminated ground water and imported foods such as rice and seafood. Studies have reported elevated thyroid antibodies, particularly TgAb in relation to arsenic exposure, which affect gene regulation through epigenetic mechanisms, and cause structural damage to thyroid tissue. Additionally, arsenic often acts antagonistically with selenium, a key nutrient for thyroid protection, potentially increasing vulnerability to autoimmune responses.[8]
References
[1] https://bioconceptsengage.com.au/eresources/clinical-foundations-hypothyroidism
[2].https://www.biomedica.com.au/media/contentmanager/content/Thyroid_Technical_Sheet
[3].https://designsforhealth.com.au/wp-content/uploads/Thyroid-Hormone-Metabolism-Bioavailability
[4] https://pubmed.ncbi.nlm.nih.gov/25931043/
[5] https://www.sciencedirect.com/science/article/pii/S221462372030017X
[6] https://pmc.ncbi.nlm.nih.gov/articles/PMC9791026/
[7] https://pubmed.ncbi.nlm.nih.gov/16807415/
[8] https://pmc.ncbi.nlm.nih.gov/articles/PMC11827576/
[9] https://pmc.ncbi.nlm.nih.gov/articles/PMC10951571/
[10] https://pmc.ncbi.nlm.nih.gov/articles/PMC9709133/
[11] https://www.ncbi.nlm.nih.gov/books/NBK459262/
[12] https://pmc.ncbi.nlm.nih.gov/articles/PMC7574993/
[13] https://pubmed.ncbi.nlm.nih.gov/28290237/
[14] https://pmc.ncbi.nlm.nih.gov/articles/PMC5621109/
[15] https://pubmed.ncbi.nlm.nih.gov/28315909/
[16].https://www.bioceuticals.com.au/education/podcasts/revolutionary-insights-autoimmune-thyroid-disease
[17] https://pubmed.ncbi.nlm.nih.gov/33569594/
[18] https://pubmed.ncbi.nlm.nih.gov/28290237/
[19] https://pubmed.ncbi.nlm.nih.gov/27043843/
[20] https://pmc.ncbi.nlm.nih.gov/articles/PMC5112739/
[21] https://pmc.ncbi.nlm.nih.gov/articles/PMC3236274/
[22] https://pmc.ncbi.nlm.nih.gov/articles/PMC9318815/
[23] https://pubmed.ncbi.nlm.nih.gov/9703374/
[24] https://pmc.ncbi.nlm.nih.gov/articles/PMC11274136/
[25] https://pmc.ncbi.nlm.nih.gov/articles/PMC11171835/
[26] https://www.mdpi.com/2076-3921/12/6/1246
[27] https://pmc.ncbi.nlm.nih.gov/articles/PMC8576104/
[28] https://pmc.ncbi.nlm.nih.gov/articles/PMC7738013/
[29].https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1530152/full
[30] https://pmc.ncbi.nlm.nih.gov/articles/PMC10426741/

bottom of page